|
⚲
|
| Ancora Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001401177 |
| Sale | 2009-11-09 ($0.8 M Sold) |
| Fund | |
| Phone | 7813957700 |
| Address | 200 Boston Ave Medford, 02155 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter Seeberger | |
| Doug Jamison | |
| Barry Buckland | |
| Karl White | |
| Mitsi Ushio | |
| John Pena | |
| Carmichael Roberts |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Gentry Felicia J
✚
|
0.0 | |
|
Gentz Timothy R
✚
|
0.0 | |
|
Genuine Risk Capital Partner Fund
✚
|
0.0 | |
|
Genzara, Inc.
✚
|
0.0 | |
|
George Arthur L Jr
✚
|
0.0 | |
|
George S. Mennen Trust fbo John H. Mennen u/a/d 11/25/1970
✚
|
0.0 | |
|
Georgia Top Choice Peanuts, LLC
✚
|
0.0 | |
|
GL-0525 Fund II AL Vehicle , a series of Chris Golda Investm
✚
|
0.0 | |
|
GL-0525 Fund II, a series of Chris Golda Investments, LP
✚
|
0.0 | |
|
Edwards Jonathan M
✚
|
0.0 |